Share on LinkedInShare on LinkedIn

ARTICLE · 30 DECEMBER 2014

Post Wisely

Morrison Foerster
Morrison Foerster
Contributor
Morrison Foerster

Morrison Foerster

With approximately 1,000 lawyers in 19 offices, Morrison & Foerster is a preeminent global law firm...

View firm profile
Explore more from Morrison Foerster

Two FDA Guidelines Help Life Sciences Companies Solve Social Media Conundrums

United StatesMedia, Telecoms, IT, Entertainment

Two FDA Guidelines Help Life Sciences Companies Solve Social Media Conundrums

Social media presents new challenges for life sciences companies. Companies that post about their products on space-constrained social media platforms such as Twitter or Facebook don't have the luxury of a full page or a long voiceover listing risks or side effects. And it's unclear how to respond to misleading information about products posted online by third parties. In June, the Food and Drug Administration produced two much-anticipated draft documents that provide some guidance in each case.

The "Twitter Guidance"

"Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices" (found at http://1.usa.gov/1kGYdgK) specifies that a brand should, within the post:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from